- List
- By Topic
- On Map
- Search Details

Myotonic Disorders
Need help? See RSS Feeds
Choose a feed type:

Myotonic Disorders (43 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT00244413 | Completed | Characteristics of Nondystrophic Myotonias |
|
Observational |
|
Other / NIH |
|
|
94 | All | 6 Years and older (Child, Adult, Older Adult) | NCT00244413 | 10263 | February 2006 | September 2012 | September 2012 | October 26, 2005 | March 6, 2013 |
|
|||||
2 | NCT02398786 | Recruiting | Myotonic Dystrophy Family Registry |
|
|
Observational |
|
Other |
|
|
3000 | All | Child, Adult, Older Adult | NCT02398786 | MDF001 | MDFR | February 2013 | February 2020 | February 2020 | March 26, 2015 | September 3, 2018 |
|
|||
3 | NCT00082108 | Recruiting | Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry |
|
Observational |
|
Other / NIH |
|
|
3000 | All | Child, Adult, Older Adult | NCT00082108 | NIAMS-104 U54NS048843 |
September 2000 | June 2023 | June 2023 | April 30, 2004 | October 4, 2018 |
|
|||||
4 | NCT02336477 | Completed | Mexiletine and Non Dystrophic Myotonias |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
24 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02336477 | P091101 | MYOMEX | June 2011 | January 2014 | January 2014 | January 13, 2015 | January 13, 2015 |
|
||
5 | NCT02251457 | Completed | Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1 |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
|
35 | All | 18 Years to 100 Years (Adult, Older Adult) | NCT02251457 | IN-US-259-1605 | August 2014 | December 18, 2017 | December 18, 2017 | September 29, 2014 | February 9, 2018 |
|
|||
6 | NCT00004802 | Completed | Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders |
|
|
Interventional |
Phase 3 |
|
NIH / Other |
|
64 | All | 10 Years to 75 Years (Child, Adult, Older Adult) | NCT00004802 | 199/11958 OSU-92H0173 |
June 1992 | February 25, 2000 | June 24, 2005 | |||||||
7 | NCT01939561 | Completed | Lamotrigine as Treatment of Myotonia |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
27 | All | 18 Years and older (Adult, Older Adult) | NCT01939561 | 2013-MY 2013-003309-24 |
November 2013 | November 2015 | November 2015 | September 11, 2013 | April 25, 2016 |
|
|||
8 | NCT02375087 | Unknown † | Sleep Breathing Disorders, a Main Trigger for Cardiac ARythmias in Type I Myotonic Dystrophy ? |
|
Observational |
|
Other |
|
|
70 | All | 18 Years and older (Adult, Older Adult) | NCT02375087 | "STAR" | STAR | May 2014 | May 2017 | September 2017 | March 2, 2015 | November 11, 2016 |
|
||||
9 | NCT02880735 | Recruiting | Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
27 | All | 18 Years and older (Adult, Older Adult) | NCT02880735 | C46-15 | September 2016 | December 2018 | April 2019 | August 26, 2016 | July 11, 2018 |
|
|||
10 | NCT03784586 | Active, not recruiting | Sudden Cardiac Death Stratification in Myotonic Dystrophy Type 1 Patients |
|
Observational |
|
Other |
|
|
51 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03784586 | 01_MD1 | February 1, 2012 | January 31, 2019 | January 31, 2019 | December 24, 2018 | December 24, 2018 | ||||||
11 | NCT03211923 | Enrolling by invitation | Muscle Relaxation in Myopathies With Positive Muscle Phenomena |
|
|
Observational |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT03211923 | NL57301.091.16 | January 5, 2017 | December 31, 2018 | December 31, 2018 | July 7, 2017 | September 13, 2018 | |||||
12 | NCT02930408 | Terminated | Compare Train and 3D-4D Left Ventricular Systolic Function in Subjects Suffering From Dystrophy and Healthy Subjects |
|
|
Interventional |
Not Applicable |
|
Other |
|
70 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT02930408 | STEINECHO | January 2014 | July 2015 | October 12, 2016 | October 12, 2016 | ||||||
13 | NCT02708784 | Unknown † | An MRI Study on Muscular Diseases -Pompe Disease and Dystrophia Myotonica- |
|
Observational |
|
Other |
|
|
60 | All | 18 Years and older (Adult, Older Adult) | NCT02708784 | PsDM15RMBH | September 2015 | August 2016 | September 2016 | March 15, 2016 | March 15, 2016 |
|
|||||
14 | NCT03764150 | Recruiting | Factors Associated With Hypoventilation in the Myotonic Dystrophy, Progressive Profile Over 5 Years |
|
Observational |
|
Other |
|
|
160 | All | 18 Years and older (Adult, Older Adult) | NCT03764150 | 2009_04/0923 2009-A00588-49 |
Steinert | June 30, 2010 | September 2019 | September 2019 | December 4, 2018 | December 4, 2018 |
|
||||
15 | NCT01242007 | Completed | Postural Spirometry Changes in Ambulatory Myotonic Dystrophy Patients |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
58 | All | 18 Years and older (Adult, Older Adult) | NCT01242007 | UNBC-11102010 | April 2008 | June 2010 | June 2010 | November 16, 2010 | November 16, 2010 |
|
|||
16 | NCT02831504 | Active, not recruiting | PhenoDM1 (Myotonic Dystrophy Type 1 Natural History Study) |
|
Observational |
|
Other |
|
|
213 | All | 18 Years and older (Adult, Older Adult) | NCT02831504 | 7491 | PhenoDM1 | August 2015 | October 31, 2018 | October 31, 2018 | July 13, 2016 | March 29, 2018 |
|
||||
17 | NCT02729597 | Completed | Tracking the Brain in Myotonic Dystrophies: a 5-year Longitudinal Follow-up Study |
|
|
Observational |
|
Other |
|
|
49 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02729597 | DM-1-2 | May 2007 | December 2014 | August 2015 | April 6, 2016 | April 6, 2016 | |||||
18 | NCT03603171 | Recruiting | Clinical Outcome Measures in Myotonic Dystrophy Type 2 |
|
|
Observational |
|
Other |
|
|
60 | All | 18 Years to 90 Years (Adult, Older Adult) | NCT03603171 | KlinikumUM | COMEDY-2 | July 1, 2018 | June 30, 2019 | December 31, 2019 | July 27, 2018 | July 27, 2018 |
|
|||
19 | NCT03692312 | Not yet recruiting | Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy |
|
|
Interventional |
Phase 2 Phase 3 |
|
Industry |
|
|
56 | All | 6 Years to 16 Years (Child) | NCT03692312 | AMO-02-MD-2-003 2016-004623-23 |
October 2018 | October 2019 | November 2019 | October 2, 2018 | October 2, 2018 |
|
|||
20 | NCT02312011 | Completed | A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1 |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
48 | All | 20 Years to 55 Years (Adult) | NCT02312011 | ISIS 598769-CS2 | December 2014 | July 2016 | August 2016 | December 9, 2014 | June 25, 2018 |
|
|||
21 | NCT03589677 | Completed | Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of Life |
|
Observational |
|
Other |
|
|
50 | All | 20 Years to 60 Years (Adult) | NCT03589677 | IRCCSSanCamillo | BrainDM | July 3, 2012 | June 4, 2015 | June 4, 2015 | July 18, 2018 | July 18, 2018 | |||||
22 | NCT03059264 | Recruiting | Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy |
|
|
Observational |
|
Other |
|
|
150 | All | up to 15 Years (Child) | NCT03059264 | HM20014211 | TREAT_CDM | December 14, 2016 | December 31, 2019 | December 31, 2019 | February 23, 2017 | October 22, 2018 |
|
|||
23 | NCT02858908 | Completed | Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
16 | All | 12 Years to 45 Years (Child, Adult) | NCT02858908 | AMO-02-MD-2-001 2016-000067-16 |
July 20, 2016 | January 2018 | January 2018 | August 8, 2016 | December 27, 2018 |
|
|||
24 | NCT00004769 | Completed | Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy |
|
Observational |
|
Other |
|
|
130 | All | 21 Years to 60 Years (Adult) | NCT00004769 | 199/11770 URMC-583 URMC-445 |
December 1993 | March 2000 | March 2000 | February 25, 2000 | January 28, 2013 | ||||||
25 | NCT03424460 | Recruiting | Venous Thromboembolism in Myotonic Dystrophy Type 1 |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
69 | All | 18 Years and older (Adult, Older Adult) | NCT03424460 | K170601J 2017-A01634-49 |
DM1-VTE | June 11, 2018 | June 2019 | September 2019 | February 7, 2018 | January 15, 2019 |
|
||
26 | NCT02308657 | Completed | Multicenter Observational Study of Myotonic Dystrophy Type 1 |
|
Observational |
|
Other / NIH / Industry |
|
|
120 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02308657 | RSRB48991 U54NS048843 |
MOS-DM1/POP | November 2013 | July 2017 | October 2017 | December 4, 2014 | October 26, 2017 |
|
||||
27 | NCT02269865 | Unknown † | Children's Health Research Institute(CHRI), Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myotonic Dystrophy |
|
Observational |
|
Other |
|
|
40 | All | 8 Years to 17 Years (Child) | NCT02269865 | 28486 | CHRI | December 2013 | December 2016 | December 2016 | October 21, 2014 | October 21, 2014 |
|
||||
28 | NCT02118779 | Completed | Observational Prolonged Trial in Myotonic Dystrophy Type 1 |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
255 | All | 18 Years and older (Adult, Older Adult) | NCT02118779 | 13/NE/0342 305697 6836 |
OPTIMISTIC | April 2, 2014 | March 29, 2016 | October 17, 2016 | April 21, 2014 | July 18, 2017 |
|
||
29 | NCT02315339 | Terminated | European Home Mechanical Ventilation Registry |
|
Observational |
|
Industry / Other |
|
|
37 | All | Child, Adult, Older Adult | NCT02315339 | CTC11633 | EHMVR | August 2014 | January 2019 | August 2019 | December 11, 2014 | October 26, 2016 |
|
||||
30 | NCT01406873 | Completed Has Results |
Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1 |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
42 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT01406873 | 3716 Funding Source: FDA/OOPD |
June 2011 | February 2017 | March 2017 | August 1, 2011 | June 19, 2018 | March 29, 2018 |
|
||
31 | NCT03141749 | Completed | Venous Thromboembolism in DM1 |
|
Observational |
|
Other |
|
|
2810 | All | 18 Years and older (Adult, Older Adult) | NCT03141749 | Institutmyologie | DM1-VTE | January 2000 | November 2014 | January 2017 | May 5, 2017 | May 9, 2017 | |||||
32 | NCT01530841 | Completed | Efficacy and Tolerance of AVAPS Mode in Myotonic Dystrophy |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
32 | All | 18 Years and older (Adult, Older Adult) | NCT01530841 | 2010-A01306-33 | July 2012 | May 2016 | May 2016 | February 10, 2012 | March 10, 2017 |
|
|||
33 | NCT01421992 | Completed | Methylphenidate in Myotonic Dystrophy Type 1 |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
28 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01421992 | AFM-12117 | June 2008 | August 2010 | September 2010 | August 23, 2011 | August 23, 2011 |
|
|||
34 | NCT01136330 | Completed | DM1 Heart Registry - DM1 Respiratory Registry |
|
Observational |
|
Other |
|
914 | All | 18 Years and older (Adult, Older Adult) | NCT01136330 | AFM-13286 | DM1-Heart-R | May 2010 | September 2011 | September 2011 | June 3, 2010 | February 20, 2012 |
|
|||||
35 | NCT02161835 | Completed | Relations Between Myotonia and Fitness |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
9 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT02161835 | H-4-2014-026 | April 2014 | February 2015 | February 2015 | June 12, 2014 | May 14, 2015 |
|
|||
36 | NCT00577577 | Unknown † | Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1 |
|
|
Interventional |
Phase 2 |
|
Industry / Other |
|
|
60 | All | 21 Years to 65 Years (Adult, Older Adult) | NCT00577577 | INSM-110-1001 | December 2007 | March 2009 | March 2009 | December 20, 2007 | July 23, 2008 |
|
|||
37 | NCT02413450 | Enrolling by invitation | Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias |
|
Observational |
|
Other |
|
|
100 | All | 18 Years to 85 Years (Adult, Older Adult) | NCT02413450 | NA_00085175 | August 2013 | August 2023 | August 2023 | April 10, 2015 | August 16, 2018 |
|
|||||
38 | NCT00745238 | Unknown † | Cardiovascular Consequences of NIV Withdrawal in Patients With Myotonic Dystrophy |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
35 | All | 18 Years and older (Adult, Older Adult) | NCT00745238 | 0801 | June 2008 | December 2012 | December 2012 | September 3, 2008 | August 13, 2012 |
|
|||
39 | NCT00167609 | Completed | Efficacy and Safety of DHEA for Myotonic Dystrophy |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
75 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT00167609 | P001108 PS001108 |
November 2004 | December 2006 | September 14, 2005 | April 6, 2010 |
|
||||
40 | NCT00233519 | Completed Has Results |
Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1) |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH / Industry |
|
|
17 | All | 21 Years to 60 Years (Adult) | NCT00233519 | 5 U54 NS048843-03 A | November 2005 | May 2008 | May 2008 | October 5, 2005 | June 25, 2012 | February 1, 2010 |
|
||
41 | NCT01225614 | Active, not recruiting | Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
77 | All | 18 Years and older (Adult, Older Adult) | NCT01225614 | P081221 2009-A01023-54 (IDRCB) |
DYVINE | October 2010 | July 2018 | December 2018 | October 21, 2010 | November 20, 2017 |
|
||
42 | NCT00622453 | Completed | Arrhythmias in Myotonic Muscular Dystrophy |
|
|
Observational |
|
Other |
|
|
448 | All | 18 Years and older (Adult, Older Adult) | NCT00622453 | 9609-31 | DM1 | September 1996 | January 2006 | February 2015 | February 25, 2008 | February 14, 2018 |
|
|||
43 | NCT00127582 | Unknown † | RAMYD Study - Evaluation of Arrhythmic Risk in Myotonic Dystrophy |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
537 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT00127582 | GUP02067 | January 2003 | August 8, 2005 | August 25, 2005 |
|
† Study has passed its completion date and status has not been verified in more than two years.